Elli, E. M.
Mauri, M.
D’Aliberti, D.
Crespiatico, I.
Fontana, D.
Redaelli, S.
Pelucchi, S.
Spinelli, S.
Manghisi, B.
Cavalca, F.
Aroldi, A.
Ripamonti, A.
Ferrari, S.
Palamini, S.
Mottadelli, F.
Massimino, L.
Ramazzotti, D.
Cazzaniga, G.
Piperno, A.
Gambacorti-Passerini, C.
Piazza, R.
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG-20112, IG-17727)
Ministero dell'Università e della Ricerca (Dipartimenti di Eccellenza 2023-2027 (l. 232/2016, art. 1, commi 314 - 337))
European Commission (NextGenerationEU through the Italian Ministry of University and Research under PNRR - M4C2-I1.3 Project PE_00000019 "HEAL ITALIA")
Università degli Studi di Milano - Bicocca
Article History
Received: 29 August 2023
Accepted: 8 November 2023
First Online: 20 January 2024
Declarations
:
: The authors have no competing interests as defined by Springer, or other interests that might be perceived to influence the results and/or discussion reported in this paper.
: This study was performed in accordance with the standards of the Helsinki Declaration. The promoter of this study is the Department of Medicine and Surgery, University of Milano-Bicocca, IRCCS, San Gerardo dei Tintori, Monza. The study (protocol 212) was approved by the Ethics Committee of ASST Monza on December 14, 2015 (Title: <i>Identification and characterization of the somatic lesions responsible for the onset of Acquired Idiopathic Erythrocytosis</i>—Code assigned: CE 0069761/15).
: I have read and understood the publishing policy and submit this manuscript in accordance with this policy.